Eli Lilly and Company

Historical 13F Holders

Symbol
LLY
CUSIP
532457108
All holders as of
Q2 2025
Type
Equity
Class
COM
Reported Value, Excluding Options
Total Filings
Period Filings Shares, Excl. Options Value, Excl. Options
2025 Q2 4,063 793 M $609 B
2025 Q1 4,078 825 M $679 B
2024 Q4 4,058 780 M $602 B
2024 Q3 3,823 799 M $694 B
2024 Q2 3,741 813 M $736 B
2024 Q1 3,633 826 M $641 B
2023 Q4 3,421 821 M $478 B
2023 Q3 3,113 787 M $423 B
2023 Q2 2,943 785 M $367 B
2023 Q1 2,731 842 M $271 B
2022 Q4 2,784 827 M $304 B
2022 Q3 2,606 799 M $259 B
2022 Q2 2,552 788 M $256 B
2022 Q1 2,438 792 M $226 B
2021 Q4 2,404 792 M $219 B
2021 Q3 2,157 792 M $183 B
2021 Q2 2,121 794 M $182 B
2021 Q1 2,035 793 M $148 B
2020 Q4 1,981 795 M $135 B
2020 Q3 1,863 736 M $109 B
2020 Q2 1,861 743 M $122 B
2020 Q1 1,778 753 M $104 B
2019 Q4 1,770 759 M $99.7 B
2019 Q3 1,615 746 M $83.5 B
2019 Q2 1,612 759 M $84.0 B
2019 Q1 1,711 783 M $101 B
2018 Q4 1,660 841 M $97.2 B
2018 Q3 1,533 848 M $90.9 B
2018 Q2 1,457 847 M $72.2 B
2018 Q1 1,419 845 M $65.4 B
2017 Q4 1,466 861 M $72.6 B
2017 Q3 1,308 851 M $72.7 B
2017 Q2 1,327 843 M $69.4 B
2017 Q1 1,349 847 M $71.2 B
2016 Q4 1,320 837 M $61.5 B
2016 Q3 1,264 836 M $67.1 B
2016 Q2 1,253 838 M $66.1 B
2016 Q1 1,219 849 M $59.9 B
2015 Q4 1,296 857 M $72.2 B
2015 Q3 1,204 852 M $71.5 B
2015 Q2 1,204 847 M $70.7 B
2015 Q1 1,164 843 M $61.3 B
2014 Q4 1,198 851 M $59.0 B
2014 Q3 1,111 840 M $54.6 B
2014 Q2 1,099 859 M $54.6 B
2014 Q1 1,097 836 M $49.6 B